Health Services Research and Pharmacy Practice

HSRPP Abstracts for Bath 2006

1. A CASE STUDY APPROACH TO THE INTERACTION OF HOSPITAL PHARMACY STAFF AND ELECTRONIC PRESCRIBING
   Smith McCaffrey GM, Cantrill JA, Tully MP.
2. A FEASIBILITY STUDY OF THE PROVISION OF BRIEF INTERVENTIONS ON ALCOHOL BY COMMUNITY PHARMACISTS
   Fitzgerald, N; McCaig, D; Thomson, D; Watson, H; Stewart, D.
3. A QUALITATIVE STUDY OF PHARMACISTS' ATTITUDES TO MEDICATION USE REVIEW (MUR) ASSESSMENT AND IDENTIFICATION OF POST ASSESSMENT LEARNING AND TRAINING NEEDS
   Davies M & Pugsley L
4. A STUDY OF UK STUDENTS' ATTITUDES TOWARDS BODY IMAGE AND WEIGHT CONTROL PRODUCTS
   Luevorasirikul K, Gray NJ, Anderson CW.
5. A SURVEY OF NURSE SUPPLEMENTARY PRESCRIBING IMPLEMENTATION IN PRIMARY AND SECONDARY CARE IN ENGLAND.
   Hobson R and Sewell G
6. A WEB-BASED STUDY OF THE PERCEIVED RISK OF SIDE EFFECTS FROM A CHEMOTHERAPY DRUG (PACLITAXEL)
   Carrigan, N., Knapp, P., Raynor, D.K., Gardner, P.H. & Woolf, E
7. ADHERENCE TO ANTIBIOTICS: ANALYSIS AND PARALYSIS
   Silcock J, Knapp P, Raynor DK, Jackson C
8. AN ANALYSIS OF PRESCRIPTION INTERVENTIONS IN COMMUNITY PHARMACY
   Jensen MA, Kairuz TE
9. AN EXPLORATION OF PHARMACY STUDENTS' ATTITUDES TOWARDS DELIVERING THE PUBLIC HEALTH AGENDA
   Morecroft, CW and Krska, J
10. ANTICOAGULATION SERVICE DEVELOPMENT THROUGH RESEARCH IN PRACTICE
    Akinwunmi F, Engová D, Duggan C , Bates I, MacCallum P
11. ASSOCIATION BETWEEN MEDICATION REGIMEN COMPLEXITY AND ACHIEVEMENT OF THERAPEUTIC GOALS IN PATIENTS WITH TYPE 2 DIABETES
    Munro K, George J, McCaig D, Cunningham S, Stewart D
12. BELIEFS ABOUT MEDICINES AMONG SWEDISH PHARMACY EMPLOYEES
    Jörgensen T, Andersson K, Mårdby A-C.
13. BRELIABLE MEASUREMENT OF PERCEPTIONS OF TUBERCULOSIS PATIENTS
    Rennie TW, Bates IP, Engova D, Bothamley GH
14. CAUSES OF PRESCRIBING ERRORS ASSOCIATED WITH THE USE OF AN ELECTRONIC PRESCRIBING SYSTEM
    O'Sullivan P, James DH, Franklin BD
15. COLLABORATIVE PRIMARY-SECONDARY CARE PHARMACISTS' SMOKING CESSATION SERVICES
    Oborne CA, Gupta S
16. COMMUNITY PHARMACY - FLEXIBLE AND FAMILY FRIENDLY: DE-BUNKING THE MYTH
    Gidman W, Hassell K, Day J, Payne K.
17. COMMUNITY PHARMACY'S ROLE IN THE MANAGEMENT AND PREVENTION OF STIs: THE VIEWS OF NHS STAKEHOLDERS
    Harris R, Anderson C
18. COMMUNITY PHARMCISTS' ETHICAL VIEWS ON EMERGENCY HORMONAL CONTRACEPTION
    Cooper R J, Bissell P, Wingfield J.
19. DEVELOPING ROLES OF PHARMACISTS AS PRESCRIBERS
    Barry Strickland-Hodge
20. DISCRETE CHOICE EXPERIMENTS' TO VALUE INCREASED ROLES FOR THE PHARMACIST IN THE MANAGEMENT OF DRUG THERAPY
    Tinelli, M., Ryan, M., Bond, C.
21. EFFECTS OF GENERIC SUBSTITUTION ON THE DEVELOPMENT OF PHARMACEUTICAL EXPENDITURES
    Karolina Andersson, Gina Bergström, Max Petzold and Anders Carlsten
22. ENHANCED COMMUNITY PHARMACY ACTIVITIES FOR METHADONE MAINTAINED PATIENTS BASED ON BEHAVIOUR CHANGE THEORY AND MOTIVATIONAL INTERVIEWING: A PILOT STUDY
    C Matheson, NM Gray, CM Bond, I Cameron, AJ Lee, B Baird, B Davidson, L Eagles.
23. ENTREPRENEURIALISM IN THE FUTURE PHARMACY WORKFORCE - WHICH STUDENTS WANT TO BE PHARMACY OWNERS?
    Shann P, Willis S, Hassell K, Noyce P, Cantril J
24. EVALUATING THE GENERAL LEVEL COMPETENCY FRAMEWORK IN PRIMARY CARE AND COMMUNITY PHARMACY: PRELIMINARY RESULTS
    Mills ER, Bates I, Davies JG, Farmer D, Webb D
25. FACILITATORS AND BARRIERS TO A COMMUNITY PHARMACY MODEL OF CARE FOR THE PROVISION OF SERVICES TO DRUG MISUSERS - A QUALITATIVE STUDY.
    Britton, R.M. and Scott, J.
26. FACTORS INFLUENCING THE CHOICE BETWEEN SELF-CARE AND HEALTH PROFESSIONAL ADVICE IN MINOR ILLNESS: A DISCRETE CHOICE EXPERIMENT
    Porteous T, Bond C, Hannaford P, Ryan M, Wyke, S.
27. FAMILY-BUILDING AND THE FUTURE PHARMACY WORKFORCE
    Willis SC, Hassell K, Shann P, Noyce P, Cantrill J.
28. HOSPITAL ADMISSIONS ASSOCIATED WITH ADVERSE DRUG REACTIONS: A META-ANALYSIS OF PROSPECTIVE OBSERVATIONAL STUDIES
    Kongkaew C, Ashcroft DM, Noyce PR
29. HOW DOES THE COST OF THE PRESCRIPTION CHARGE MATTER TO ASTHMA PATIENTS?
    Schafheutle EI
30. INFLUENCE OF PRESCRIPTION CHARGES ON REPEAT PRESCRIBING IN PRIMARY CARE
    Bradley F, Elvey R, Ashcroft D M & Noyce P
31. INFORMATION-RELATED ROLES AND PHARMACISTS: PUBLIC OPINION
    Mackridge AJ, Marriott JF
32. INVOLVING PATIENTS IN THE RESEARCH PROCESS: A DESCRIPTIVE EVALUATION
    Weiss MC, Sutton J, Adams C
33. IS PULSE RATE A POTENTIAL MEASURE OF ADHERENCE IN PATIENTS TAKING BETABLOCKERS?
    MacAdam A, Ellis-Martin M and Rowe S
34. LAY PERSPECTIVES ON THE PRESCRIBING OF MEDICINES FOR DEMENTIA
    Taylor, D.A, Weiss M.C.
35. LEADERS' VIEWS ON THE APPLICABILITY OF PDRM INDICATORS IN COMMUNITY PRACTICE: A PORTUGUESE QUALITATIVE STUDY
    Guerreiro MP, Cantrill JA, Martins AP
36. MEDICATION REVIEW BY NURSES, PHARMACISTS AND GPS: A PILOT PUBLIC CAMPAIGN
    Krska J,Gill D,Hansford D.
37. NEEDLE EXCHANGE PHARMACIST'S VIEWS ON RESPONSIBILITIES FOR TRAINING
    Scott J , Davey C, Dodridge E, Khan K and Millington Z
38. PATIENT PRESSURE - AN UNCOMFORTABLE ISSUE FOR SECONDARY CARE PRESCRIBERS?
    Lewis PJ, Hassell K, Tully MP.
39. PHARMACISTS' DESCRIPTIONS OF THEIR PERSONAL VIEWS AND EXPERIENCES OF NON-PRESCRIPTION SIMVASTATIN AND OMEPRAZOLE
    Hansford D, Cunningham S, John DN, McCaig D and Stewart D
40. PHARMACOGENETICS: THE NEXT CHALLENGE FOR PHARMACY?
    Clemerson JP, Payne K, Bissell P, Anderson C.
41. PHARMACOVIGILANCE AND THE ROLE OF META-ANALYSIS: RISK OF MYOCARDIAL INFARCTION ASSOCIATED WITH SELECTIVE COX-2 INHIBITORS
    Chen L, Ashcroft DM
42. PHARMACY PREMISES: PHARMACISTS VIEWS ON THE NEW CONTRACT
    Adams A, Hall J, Smith I
43. POSITIVE BENEFITS OF A PHARMACIST MANAGED HYPERTENSION CLINIC IN NIGERIA
    Agbani E., Erhun W and Bolaji E.E.
44. PRESCRIBING AND THE INTERFACE BETWEEN PRIMARY AND SECONDARY CARE
    Crowe S, Tully MP, Cantrill JA.
45. PRIORITISATION OF PHARMACEUTICAL NEEDS IN A COMMUNITY HOSPITAL SETTING IN DUMFRIES AND GALLOWAY.
    Flynn A, Pfleger D.
46. RCT OF COMMUNITY PHARMACY BASED CLINICAL MEDICATION REVIEW WITH AND WITHOUT ACCESS TO PATIENT'S SUMMARY MEDICAL PROFILES
    MacLaren AG, Mackie CA, Tennant S
47. "SAFE AND EFFECTIVE USE OF MEDICINES" A QUICK SCREEN INSTRUMENT FOR NON-ADHERENCE
    
    Rossing C, Fonnesbæk L, Frøkjær B, Herborg H, Sørensen L, Tomsen D
48. SELECTING A METHODOLOGY TO STUDY PROCESS: LESSONS FROM A SYSTEMATIC REVIEW OF THE EFFECTIVENESS, ROLE AND VALUE OF WRITTEN MEDICINES INFORMATION FOR PATIENTS
    Grime, J.; Blenkinsopp, A.
49. SKILL MIX IN COMMUNITY PHARMACY: OBSERVING THE IMPACT OF REPEAT DISPENSING
    Elvey R, Ashcroft DM, Morecroft C, Noyce P.
50. STAKEHOLDERS' PERSPECTIVE OF BARRIERS TO THE USE OF THE PHARMACY FIRST MINOR AILMENTS SCHEME
    Pumtong S, Anderson C, Bissell P, Boardman H
51. SUPPLEMENTARY PRESCRIBING: EARLY EXPERIENCES OF RPSGB REGISTERED PRESCRIBERS
    George J, McCaig D, Bond C1, Cunningham S, Diack L, Watson A2, Stewart D
52. THE APPLICATION OF ROOT CAUSE ANALYSIS TO EXPLORE THE FAILURE OF PATIENT RECRUITMENT FOR MEDICATION REVIEWS IN THE COMMUNITY PHARMACY SETTING.
    E.K. Rosenbloom N. Barnett R. Esmail, C. Jenner, R. Foulsham, A. Jenkins
53. THE EFFECT OF COMMUNICATION SKILLS TRAINING ON CONSULTATIONS FOR NON-PRESCRIPTION MEDICINES
    Watson MC, Inch J, Cleland J, Francis J, Bond CM.
54. THE INFLUENCE OF CLINICAL TRAINING ON SELF-ASSESSED COMPETENCE IN COMMUNITY PHARMACISTS
    Laaksonen R, Mills R, Bates I, Duggan C, Davies G, Mackie C
55. THE NEW CONTRACT: WHAT LEVEL OF SUPPORT DO PHARMACISTS FEEL THEY HAVE RECEIVED?
    Smith I, Hall J, Adams A
56. THE USE OF THREE QUALITATIVE METHODS TO EVALUATE PHARMACISTS' VIEWS ABOUT THE RPSGB's PILOT CPD FEEDBACK SYSTEM
    James DH, John DN, Hughes ML, Dewdney R, Temple D, Davies M & Roberts D
57. THE USE OF UNDERGRADUATE MULTI-DISCIPLINARY TEAM WORKING TO IMRPOVE UNDERSTANDING OF CARE OF THE ELDERLY
    Gibson M, Diack L
58. TRAINING COMMUNITY PHARMACISTS FOR A CLINICAL MEDICATION REVIEW SERVICE
    Harris DJ, Senior Lecturer and Lacey J
59. USE OF FOLLOW-UP INDIVIDUAL INTERVIEWS WITH FOCUS GROUP PARTICIPANTS. ARE THEY WORTH THE ADDITIONAL EFFORT?
    John DN & Jones ER
60. WHAT DO FEMALE COMMUNITY PHARMACISTS THINK THEY ARE WORTH?
    Gidman W, Hassell K, Day J, Payne K.
61. WHY ARE PHARMACISTS NOT DOING MURs?
    Hall J, Smith I, Adams A.